Innovative Blood Pressure Monitoring Hilo specializes in cuffless, AI-powered blood pressure monitoring technology that offers continuous and accessible insights. This innovation positions the company well to partner with healthcare providers and device manufacturers seeking to enhance remote patient monitoring and wearable health solutions.

Strong R&D and Patent Portfolio With over 120 peer-reviewed publications and more than 35 patents, Hilo demonstrates a significant investment in research and development. This indicates a competitive edge that can be leveraged for collaborations or licensing opportunities with other health technology firms and academic institutions.

Global Expansion Focus Headquartered in Switzerland and expanding internationally, Hilo presents opportunities to explore partnerships with global healthcare organizations and distributors interested in innovative cardiovascular monitoring devices, especially in markets with increasing demand for remote health management.

Recent Funding Milestone Having secured $41.3 million in Series B funding, Hilo is positioned for growth and product deployment. Healthcare services and insurance companies may find value in strategic collaborations to incorporate Hilo’s technology into integrated health management solutions.

Target Patient Segments Given Hilo’s focus on continuous blood pressure monitoring, potential sales opportunities exist within telehealth services, senior care providers, and chronic disease management programs, where real-time blood pressure data can significantly improve patient outcomes and care efficiency.